Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Politics

Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

by admin April 4, 2025
April 4, 2025
Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

Dr. Mehmet Oz will serve as the next administrator of the Centers for Medicare and Medicaid Services after the full Senate voted along party lines to confirm his nomination on Thursday. 

The former daytime TV doctor turned politician will be in charge of nearly $1.5 trillion in federal healthcare spending. His duties will entail overseeing Medicare, Medicaid and the Children’s Health Insurance Program (CHIP), including directing decisions related to how the government covers procedures, hospital stays and medication, as well as the reimbursement rates at which healthcare providers get paid for their services.   

Medicare is a federal healthcare program for seniors aged 65 and up, and currently provides coverage to about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, a public health assistance program for people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov. Meanwhile, CHIP, which provides free or low-cost health coverage for eligible low-income children and family members, assists around 7.2 million individuals. 

A graduate of Harvard University, Oz received medical and business degrees from the University of Pennsylvania. He is a former heart surgeon who saw his fame rise through his appearances on daytime television, including ‘The Oprah Winfrey Show,’ and 13 seasons of ‘The Dr. Oz Show.’

Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He lost to John Fetterman, then the state’s lieutenant governor.

‘Dr. Oz has a strong desire to modernize CMS and encourage healthy lifestyles for all Americans, including by focusing on the underlying causes of chronic disease and implementing innovative technologies,’ Senate Finance Committee Chairman Sen. Mike Crapo, R-Idaho, said Thursday.

Crapo, who led Oz’s nomination process at the committee level, commended Oz for his ‘diligence and accessibility’ throughout the process, including his willingness to answer ‘hundreds’ of questions for the record.

Those questions came from both Republicans and Democrats. They included asking about Oz’s stance on abortion, transgender medical treatments, Medicare privatization, prescription drug pricing and more. Potential financial conflicts of interest were also a concern among Democratic lawmakers throughout Oz’s confirmation process. Oz has committed to divesting any holdings that may pose an issue. 

Thursday’s confirmation comes as the Trump administration continues to work to finalize the rest of its political appointments, including notably the president’s pick to be the next United Nations ambassador and his pick for director of the Consumer Financial Protection Bureau. 

Per The Washington Post’s ‘political appointee tracker,’ there are currently still 233 nominees being considered by the Senate.

This post appeared first on FOX NEWS

previous post
Republicans charge ahead on Trump budget, setting up marathon Senate votes
next post
Here’s a closer look at Trump’s tariff plan: What to know about the new duties

Related Posts

President Trump urged to pardon 76-year-old grandmother, others...

January 22, 2025

Here’s what happened during President Donald Trump’s 5th...

February 22, 2025

Top agency staffer trying to block crucial Trump...

March 27, 2025

Where Zelenskyy is headed following tense White House...

March 1, 2025

CIA Director Ratcliffe hits back on Dem senator’s...

March 26, 2025

Trump rattles off ‘flagrant scams’ uncovered by DOGE,...

February 23, 2025

Federal courts will not make criminal referrals to...

January 4, 2025

Reverend asks Trump to have ‘mercy’ on immigrants,...

January 22, 2025

Rubio to pitch foreign policy credentials to Senate...

January 15, 2025

Trump signs late-night executive order abolishing handful of...

February 20, 2025

Recent Posts

  • Emerging Stocks to Watch – Breakouts, Momentum & Upgrades!
  • S&P 500, Bitcoin & XLK: What the Charts Are Saying Now
  • MACD + ADX: Spot the Pullbacks Worth Trading
  • S&P 500 Slide Explained: What Past Price Action Reveals About Market Dips
  • Republicans look to stop China’s ‘backdoor’ tariff dodging scheme

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • Emerging Stocks to Watch – Breakouts, Momentum & Upgrades!

    May 23, 2025
  • S&P 500, Bitcoin & XLK: What the Charts Are Saying Now

    May 23, 2025
  • MACD + ADX: Spot the Pullbacks Worth Trading

    May 23, 2025
  • S&P 500 Slide Explained: What Past Price Action Reveals About Market Dips

    May 23, 2025
  • Republicans look to stop China’s ‘backdoor’ tariff dodging scheme

    May 23, 2025
  • Trump has not directed admin to declassify Biden docs on health ‘cover-up’

    May 23, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 3

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 4

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 5

    Trudeau declares himself ‘proud feminist’ after lamenting Harris loss to Trump as setback for women

    December 13, 2024
  • 6

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 7

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
Promotion Image

banner

Categories

  • Business (365)
  • Investing (1,182)
  • Politics (1,474)
  • Stocks (478)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved